How many insider declarations has Mr. Praveen D Kurkal filed?

Mr. Praveen D Kurkal has filed 3 public insider declarations with SEBI (PIT + SAST).

What is Mr. Praveen D Kurkal's role?

Mr. Praveen D Kurkal's reported role is not specified by the regulator across the filings.

Which companies does Mr. Praveen D Kurkal report trades for?

Mr. Praveen D Kurkal reports trades for Glenmark Pharmaceuticals Limited.

← Executives ★ Sign in to follow

MP

Mr. Praveen D Kurkal

IN·SEBI (PIT + SAST)

Glenmark Pharmaceuticals Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the detailed record of transactions filed by Mr. Praveen D Kurkal. Director active across 1 company, notably Glenmark Pharmaceuticals Limited. Aggregated, 3 disclosures have been recorded. History available since 20 September 2023. The latest transaction was filed on 20 September 2023 (Sale). Regulator: SEBI (PIT + SAST). All data is openly available.

Declarations3 total

●

Mr. Praveen D Kurkal

Executives20 Sept 2023Glenmark Pharmaceuticals Limited

₹852,0006SEBI ↗

1,000 shares@ ₹852.0040.0% of flowEquity SharesSEBI:7c43f029fcf65d701002d87cbc38f4b76c05691e

●

Mr. Praveen D Kurkal

Executives20 Sept 2023Glenmark Pharmaceuticals Limited

₹852,0006SEBI ↗

1,000 shares@ ₹852.0040.0% of flowEquity SharesSEBI:4735f3b198350556570238ed4d2ffa4d36737a5f

●

Mr. Praveen D Kurkal

Executives20 Sept 2023Glenmark Pharmaceuticals Limited

₹425,5104SEBI ↗

500 shares@ ₹851.0220.0% of flowEquity SharesSEBI:e66100d169abd1b49336835c9bcfd5956cdd6833

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

MP

Mr. Praveen D Kurkal

IN·SEBI (PIT + SAST)

Glenmark Pharmaceuticals Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the detailed record of transactions filed by Mr. Praveen D Kurkal. Director active across 1 company, notably Glenmark Pharmaceuticals Limited. Aggregated, 3 disclosures have been recorded. History available since 20 September 2023. The latest transaction was filed on 20 September 2023 (Sale). Regulator: SEBI (PIT + SAST). All data is openly available.

Declarations3 total

●

Mr. Praveen D Kurkal

Executives20 Sept 2023Glenmark Pharmaceuticals Limited

₹852,0006SEBI ↗

1,000 shares@ ₹852.0040.0% of flowEquity SharesSEBI:7c43f029fcf65d701002d87cbc38f4b76c05691e

●

Mr. Praveen D Kurkal

Executives20 Sept 2023Glenmark Pharmaceuticals Limited

₹852,0006SEBI ↗

1,000 shares@ ₹852.0040.0% of flowEquity SharesSEBI:4735f3b198350556570238ed4d2ffa4d36737a5f

●